freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Prostate cancer drug Abiraterone turned down by NICE, but available for patients with private medical cover

Published on 02/02/2012

Abiraterone, a drug that extends the life of prostate cancer sufferers, has been provisionally rejected for use on the NHS. However, it will still be available to patients with private medical insurance.

More than 10,000 die of prostate cancer in the UK each year, making it the second most common cause of cancer death in men.

Abiraterone has been turned down for use on the NHS

Abiraterone is one of the few drugs available to men in the final stages of prostate cancer. It can extend their life by more than 3 months, and kept bomber Abdel Basset Al-Megrahi alive for two years longer than predicted.

The drug costs just under £3,000 for one month’s supply but has been offered at an undisclosed discounted price to the NHS.

However, draft guidance from NICE says the drug’s benefits are not enough to justify the pay for use in England and Wales.

The chief executive of the National Institute for Health and Clinical Excellence (NICE), Sir Andrew Dillon, said the drug was effective, and one of its key benefits was that it could be taken orally in the patient's own home.

"We are therefore disappointed not to be able to recommend it for use on the NHS, however it is an expensive drug," Sir Andrew added.

Until final guidelines are issued by the health regulator, decisions can continue to be made locally about the use of abiraterone. Cancer charities have been angered by the decision.

But patients with private medical insurance WILL be covered on their policy for use of abiraterone.

Full cancer cover with insurers like Aviva, Bupa and PruHealth will cover you for treatment like Abiraterone, despite being deemed too expensive for use on the NHS.

Abiraterone is not the only drug that NICE has turned down. Avastin, successful at treating ovarian cancer and brain cancer, is not available for use on the NHS. However, patients with private medical cover will have access to it in the future.

Compare health insurance online now to get covered for use of these lifesaving drugs.

© ActiveQuote Ltd. 2012

Categories:  MedicalNHS and Hospitals
Prostate cancer drug Abiraterone turned down by NICE, but available for patients with private medical coverAbiraterone, a drug that extends the life of prostate cancer sufferers, has been provisionally rejected for use on the NHS. However, it wi    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member

The advisor was incredibly helpful and fully explained the differences between the policies. I really liked the fact that I was put under no pressure.

Review centre member

I was pleasantly surprised with the in-depth knowledge, the efficiency and the nice and polite manner of the staff - the explanations were made very clearly.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...